Dopamine replacement therapy does not restore the full spectrum of normal pallidal activity in the 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine primate model of Parkinsonism
Gali Heimer, Michal Rivlin-Etzion, Izhar Bar-Gad, Joshua A. Goldberg, Suzanne N. Haber, Hagai Bergman
Research output: Contribution to journal › Article › peer-review
96Scopus
citations
Fingerprint
Dive into the research topics of 'Dopamine replacement therapy does not restore the full spectrum of normal pallidal activity in the 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine primate model of Parkinsonism'. Together they form a unique fingerprint.